Jade Biosciences (JBIO) Total Non-Current Liabilities (2021 - 2025)
Jade Biosciences (JBIO) posted Total Non-Current Liabilities of $160.97 million for Q1 2025, up 915.8% from $15.85 million a year earlier and up 34.7% from the prior quarter.
Powered by 
Analysis
Jade Biosciences (JBIO) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends
At the end of FY2024, Jade Biosciences' Total Non-Current Liabilities came in at $119.53 million, up 568.1% from FY2023.
- Annual Total Non-Current Liabilities has increased for three consecutive years, with a three-year compound annual growth rate of 244.2% (FY2021 to FY2024).
- In prior years, Jade Biosciences' Total Non-Current Liabilities was $17.89 million in FY2023 (+110.8%), $8.49 million in FY2022 (+189.5%) and $2.93 million in FY2021.
- The Q1 2025 figure stands as the highest quarterly Total Non-Current Liabilities in data going back to Q4 2021.
- On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last ten quarters, with growth averaging 405.1% over the last eight quarters.
- Over the past five years, the year-over-year growth in Total Non-Current Liabilities ranged from 41.1% (Q1 2024) to 915.8% (Q1 2025).
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $119.53 million (Q4 2024), $107.75 million (Q3 2024) and $112.21 million (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Jade Biosciences | 901.23 Mn | 901.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 160.97 Mn |
| Dec 31, 2024 | 119.53 Mn |
| Sep 30, 2024 | 107.75 Mn |
| Jun 30, 2024 | 112.21 Mn |
| Mar 31, 2024 | 15.85 Mn |
| Dec 31, 2023 | 17.89 Mn |
| Sep 30, 2023 | 15.08 Mn |
| Jun 30, 2023 | 13.76 Mn |
| Mar 31, 2023 | 11.23 Mn |
| Dec 31, 2022 | 8.49 Mn |
| Sep 30, 2022 | 8.51 Mn |
| Jun 30, 2022 | 4.62 Mn |
| Mar 31, 2022 | 5.04 Mn |
| Dec 31, 2021 | 2.93 Mn |
API Access
Jade Biosciences Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=JBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "JBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=JBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();